Deep Tech Pioneers
Contact us

AI-native drug discovery with patient relevant brain organoids

Accelerating the development of life-changing therapies

Amazon Web Services, AWS, and the ‘Powered by AWS’ logo are trademarks of Amazon.com, Inc. or its affiliates.
Our solutions

Technology of minibrains

At BrainZell, we specialize in generating high-throughput brain organoids derived from induced pluripotent stem cells (iPSCs). Our innovative platform closely mimics human neural biology and includes key components of the brain’s immune system, an important driver of brain diseases.

Learn more about our technology

Why BrainZell?

High throughput drug discovery platform

BrainZell's platform combines high-throughput brain organoid experiments with advanced computational modeling to discover new biology and drug targets.

>10.000

Datapoints

Every week

Industrial-scale brain organoids

Produced in automated robotic lab.

Contact us

Brain architecture with neuroimmune system

Naturally developed neural cell populations creating human brain microenvironment.

Contact us

Biology maps showing efficacy and side effects

BrainZell measures multimodal live phenotypes and computes biological maps for each organoid, measuring brain biology in real life.

Contact us
Contact us

Pioneering the future
new Central Nervous System (CNS) drug development

Human cortical models

Faithfully mimic the human brain

Mice are not humans, it's time to develop human brain medicines using human cell-based technologies and human relevant models.

Contact us to learn more

News

Discover our latest news and Scientific articles

Discover more articles
Published work about p53 in brain organoids.
Read article
Published work about 3D single-cell imaging in brain organoids
Read article
Published work about antiviral treatments of Zika virus tested in brain organoids.
Read article